
Research Square (Research Square), Год журнала: 2024, Номер unknown
Опубликована: Окт. 21, 2024
Язык: Английский
Research Square (Research Square), Год журнала: 2024, Номер unknown
Опубликована: Окт. 21, 2024
Язык: Английский
Journal of Orthopaedic Translation, Год журнала: 2025, Номер 50, С. 44 - 55
Опубликована: Янв. 1, 2025
Язык: Английский
Процитировано
1European Spine Journal, Год журнала: 2025, Номер unknown
Опубликована: Фев. 6, 2025
Язык: Английский
Процитировано
0Journal of Controlled Release, Год журнала: 2025, Номер 380, С. 599 - 614
Опубликована: Фев. 15, 2025
Язык: Английский
Процитировано
0Journal of Extracellular Vesicles, Год журнала: 2025, Номер 14(3)
Опубликована: Март 1, 2025
ABSTRACT Mesenchymal stem/stromal cells (MSCs) are a valuable source of paracrine factors, as they have remarkable secretory capacity, and there is sizeable knowledge base to develop industrial clinical production protocols. Promising cell‐free approaches for tissue regeneration immunomodulation driving research towards secretome applications, among which extracellular vesicles (EVs) steadily gaining attention. However, the manufacturing application EVs limited by insufficient yields, gaps, low standardization. Facing these limitations, hydrogels represent versatile three‐dimensional (3D) culture platform that can incorporate matrix (ECM) components mimic natural stem cell environment in vitro; via niche‐mimicking properties, regulate MSCs’ morphology, adhesion, proliferation, differentiation secretion capacities. impact hydrogel's architectural, biochemical biomechanical properties on remains poorly understood, field still its infancy interdependency parameters compromises comparability studies. Therefore, this review summarizes discusses reported effects hydrogel encapsulation MSC‐EVs. Considering cell‐material interactions overall activity MSCs, we identify persistent challenges from standardization process control, outline future paths research, such synergic use bioreactors enhance MSC‐EV generation.
Язык: Английский
Процитировано
0Materials Today Bio, Год журнала: 2024, Номер 28, С. 101251 - 101251
Опубликована: Сен. 14, 2024
Язык: Английский
Процитировано
1bioRxiv (Cold Spring Harbor Laboratory), Год журнала: 2024, Номер unknown
Опубликована: Дек. 14, 2024
Background: Small extracellular vesicles (sEV) are a conserved mean of communication across the domains life and lately gained more interest in mammalian non-cancerous work as non-cellular, biological therapeutic with encouraging results recent studies chronic degenerative diseases. The nucleus pulposus (NP) is avascular aneural center an intervertebral disc (IVD), home to unique niche conditions affected IVD degeneration. We investigated proteome autologous mesenchymal stem cell (MSC) sEVs for their potential contribute tissue homeostasis this niche. Methods: aimed identify characteristics NP via mass spectrometric functional enrichment analysis. explored profile generated by parent lines from bovine coccygeal adipose tissue, focus on cells, using adult fetal donors. compared these findings published sEV databases MSC data. Findings: propose several mechanisms associated sEVs: 1. Membrane receptor trafficking modify signal responses promoting homeostasis. 2. Cell proteasome delivery; 3. Redox energy metabolic enzymes delivery. 4. Immunomodulation beyond association serum protein corona. Conclusion: signature cells similar previously data, yet supplementing anaerobic metabolism redox balance while contributing maintenance microniche.
Язык: Английский
Процитировано
1International Journal of Biological Macromolecules, Год журнала: 2024, Номер 292, С. 139238 - 139238
Опубликована: Дек. 27, 2024
Язык: Английский
Процитировано
0Bioengineering, Год журнала: 2024, Номер 11(6), С. 591 - 591
Опубликована: Июнь 10, 2024
Degenerative disc disease (DDD) is a pervasive condition that limits quality of life and burdens economies worldwide. Conventional pharmacological treatments primarily aimed at slowing the progression degeneration have demonstrated limited long-term efficacy often do not address underlying causes disease. On other hand, orthobiologics are regenerative agents derived from patient's own tissue represent promising emerging therapy for degenerative This review comprehensively outlines pathophysiology DDD, highlighting inadequacies existing therapies detailing potential orthobiologic approaches. It explores advanced tools such as platelet-rich plasma mesenchymal stem cells, providing historical overview their development within medicine, foundational in vitro studies to preclinical animal models. Moreover, manuscript delves into clinical trials assess effectiveness these managing DDD. While current evidence promising, it remains insufficient routine adoption due limitations study designs. The emphasizes need further research optimize consistent effective outcomes, potentially revolutionizing management DDD offering renewed hope patients.
Язык: Английский
Процитировано
0Biochemical and Biophysical Research Communications, Год журнала: 2024, Номер 734, С. 150778 - 150778
Опубликована: Окт. 1, 2024
Язык: Английский
Процитировано
0Nanomedicine Nanotechnology Biology and Medicine, Год журнала: 2024, Номер unknown, С. 102790 - 102790
Опубликована: Окт. 1, 2024
Язык: Английский
Процитировано
0